INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/20/2024
Back to search
Official data from USPTO
BELOGAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/20/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/02/2016
Registration date
03/14/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/29/2023
Last transaction
09/29/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SE
Examiner
LAVACHE, LINDA M
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Double Bond Pharmaceuticals AB
Representatives
Mark Harrison Venable LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsanti-cancer preparations and preparations for treatment of central nervous system diseasesimmune system disordersmetabolic diseaseslung diseasesbacterial and fungal infections; pharmaceutical preparations for tissue targeting for the treatment of cancerimmune system disorderscentral nervous system diseasesmetabolic diseaseslung diseasesbacterial and fungal infections; pharmaceutical preparations for controlled release of anti-cancer drugs and drugs for the treatment of immune system disorderscentral nervous system diseasesmetabolic diseaseslung diseasesbacterial and fungal infections; chemical preparations for pharmaceutical purposesfor the treatment of cancerimmune system disorderscentral nervous system diseasesmetabolic diseaseslung diseasesbacterial and fungal infections; chemical preparations for medical purposesfor the treatment of cancerimmune system disorderscentral nervous system diseasesmetabolic diseaseslung diseasesbacterial and fungal infections; chemical preparations for veterinary purposesfor the treatment of cancerimmune system disorderscentral nervous system diseasesmetabolic diseaseslung diseasesbacterial and fungal infections in mammals; veterinary preparations for the treatment of cancerimmune system disorderscentral nervous system diseasesmetabolic diseaseslung diseasesbacterial and fungal infections in mammals
Publications
History of USPTO decisions and trademark events.
30 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/27/2024
INPC
INVALIDATION PROCESSED
06/27/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/14/2024
C71T
CANCELLED SECTION 71
09/29/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/14/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/23/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/08/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/21/2017
FIMP
FINAL DISPOSITION PROCESSED
06/21/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/14/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/14/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/27/2016
PUBO
PUBLISHED FOR OPPOSITION
12/27/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/07/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2016
RFNT
REFUSAL PROCESSED BY IB
11/18/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/01/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/27/2016
RFRR
REFUSAL PROCESSED BY MPU
10/27/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/15/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/08/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/07/2016
CNRT
NON-FINAL ACTION WRITTEN
10/06/2016
DOCK
ASSIGNED TO EXAMINER
10/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/04/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/01/2016
Continuous trademark protection
Get notified about every new filing that threatens BELOGAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.